drugset / Trial / NCT02148328
Safety, Tolerability, and Immunogenicity Study of a Cell-based Virosomal Influenza Vaccine in Healthy Adults
RandomizedParallel-groupDouble-blindPrevention
Summary
The purpose of this study is to examine the safety and tolerability after administration of trivalent and quadrivalent cell-based virosomal influenza vaccine in healthy adults.
Timeline
- Start
- 2014-05
- Primary completion
- 2014-10
- Completion
- 2014-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Quadrivalent commercial influenza vaccine | Vaccine | — | Intramuscular |
| Subject | Quadrivalent virosomal influenza vaccine | Vaccine | — | Intramuscular |
| Comparator | Trivalent commercial virosomal influenza vaccine | Vaccine | — | Intramuscular |
| Subject | Trivalent virosomal influenza vaccine | Vaccine | — | Intramuscular |